BioCentury | Jul 17, 2014
Strategy

Partnering in pediatrics

...treat merosin-deficient congenital muscular dystrophy type 1A (MDC1A), and to license PRT-01 directly from the University of Nevada...
...Inc. , Cambridge, Mass. Persepsys Biomedical LLC , Cincinnati, Ohio Prothelia Inc. , Milford, Mass. University of Nevada...
BioCentury | Feb 17, 2014
Company News

Alexion, Prothelia, University of Nevada deal

...declined to provide details. Alexion Pharmaceuticals Inc. (NASDAQ:ALXN), Cheshire, Conn. Prothelia Inc. , Milford, Mass. University of Nevada...
BioCentury | Feb 14, 2014
Company News

Alexion gains option to acquire Prothelia

...merosin-deficient congenital muscular dystrophy type 1A (MDC1A). Prothelia has rights to the laminin-111 from the University of Nevada...
BioCentury | Mar 7, 2011
Company News

Immuno-Mycologics, University of Nevada deal

...HIV/AIDS-related deaths in developing countries. Further terms were not disclosed. Immuno-Mycologics Inc. , Norman, Okla. University of Nevada...
BioCentury | May 26, 2003
Company News

Samaritan board of directors update

...Vegas, Nev. Business: Infectious diseases Appointed: Erasto Saldi, chief resident of internal medicine at the University of Nevada...
BioCentury | Feb 24, 2003
Company News

Seattle Genetics scientific advisory board update

...Seattle, Wash. Business: Antibodies, Cancer Appointed: William Murphy, professor of microbiology and immunology at the University of Nevada...
BioCentury | Nov 11, 2002
Company News

Samaritan scientific advisory board update

...Vegas, Nev. Business: Infectious diseases Appointed: Erasto Saldi, chief resident of internal medicine at the University of Nevada...
BioCentury | Feb 2, 1998
Emerging Company Profile

NaviCyte Inc.

...Sinko, John Wehrli and Michael Crawford Corporate partners: SmithKline Beecham , Genentech Inc. University collaborators: University of Nevada...
Items per page:
1 - 8 of 8
BioCentury | Jul 17, 2014
Strategy

Partnering in pediatrics

...treat merosin-deficient congenital muscular dystrophy type 1A (MDC1A), and to license PRT-01 directly from the University of Nevada...
...Inc. , Cambridge, Mass. Persepsys Biomedical LLC , Cincinnati, Ohio Prothelia Inc. , Milford, Mass. University of Nevada...
BioCentury | Feb 17, 2014
Company News

Alexion, Prothelia, University of Nevada deal

...declined to provide details. Alexion Pharmaceuticals Inc. (NASDAQ:ALXN), Cheshire, Conn. Prothelia Inc. , Milford, Mass. University of Nevada...
BioCentury | Feb 14, 2014
Company News

Alexion gains option to acquire Prothelia

...merosin-deficient congenital muscular dystrophy type 1A (MDC1A). Prothelia has rights to the laminin-111 from the University of Nevada...
BioCentury | Mar 7, 2011
Company News

Immuno-Mycologics, University of Nevada deal

...HIV/AIDS-related deaths in developing countries. Further terms were not disclosed. Immuno-Mycologics Inc. , Norman, Okla. University of Nevada...
BioCentury | May 26, 2003
Company News

Samaritan board of directors update

...Vegas, Nev. Business: Infectious diseases Appointed: Erasto Saldi, chief resident of internal medicine at the University of Nevada...
BioCentury | Feb 24, 2003
Company News

Seattle Genetics scientific advisory board update

...Seattle, Wash. Business: Antibodies, Cancer Appointed: William Murphy, professor of microbiology and immunology at the University of Nevada...
BioCentury | Nov 11, 2002
Company News

Samaritan scientific advisory board update

...Vegas, Nev. Business: Infectious diseases Appointed: Erasto Saldi, chief resident of internal medicine at the University of Nevada...
BioCentury | Feb 2, 1998
Emerging Company Profile

NaviCyte Inc.

...Sinko, John Wehrli and Michael Crawford Corporate partners: SmithKline Beecham , Genentech Inc. University collaborators: University of Nevada...
Items per page:
1 - 8 of 8